MaoC, KulasingamSL, WhithamH, HawesS, LinJ, KiviatN. Clinican and patient acceptability of self-collected human papillomavirus testing for cervical cancer screening. J Womens Health, 2017; 26:609–615.
2.
CrosbyRA, HagenseeME, VanderpoolR, et al.Community-based screening for cervical cancer: A feasibility study of rural Appalachian women. Sex Transm Dis, 2015; 42:607–611.
3.
ScarinciIC, LittonAG, Garces-PalacioIC, PartridgeEE, CastlePE. Acceptability and usability of self-collected sampling for HPV testing among African-American women living in the Mississippi Delta. Womens Health Issues, 2013; 23:e123–e130.
4.
SewaliB, OkuyemiKS, AskhirA, et al.Cervical cancer screening with clinic-based Pap test versus home HPV test among Somali immigrant women in Minnesota: A pilot randomized controlled trial. Cancer Med, 2015; 4:620–631.
5.
BarbeeL, KobetzE, MenardJ, et al.Assessing the acceptability of self-sampling for HPV among Haitian immigrant women: CBPR in action. Cancer Causes Control, 2010; 21:421–431.
6.
De AlbaI, Anton-CulverH, HubbellFA, et al.Self-sampling for human papillomavirus in a community setting: Feasibility in Hispanic women. Cancer Epidemiol Biomarkers Prev, 2008; 17:2163–2168.
7.
WikstromI, LindellM, SannerK, WilanderE. Self-sampling and HPV testing or ordinary Pap-smear in women not regularly attending screening: A randomised study. Br J Cancer, 2011; 105:337–339.
8.
GokM, HeidemanDA, van KemenadeFJ, et al.HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: Cohort study. BMJ, 2010; 340:c1040.
9.
VirtanenA, AnttilaA, LuostarinenT, NieminenP. Self-sampling versus reminder letter: Effects on cervical cancer screening attendance and coverage in Finland. Int J Cancer, 2011; 128:2681–2687.
10.
ArrossiS, ThouyaretL, HerreroR, et al.Effect of self-collection of HPV DNA offered by community health workers at home visits on uptake of screening for cervical cancer (the EMA study): A population-based cluster-randomised trial. Lancet Glob Health, 2015; 3:e85–e94.
11.
BansilP, WittetS, LimJL, WinklerJL, PaulP, JeronimoJ. Acceptability of self-collection sampling for HPV-DNA testing in low-resource settings: A mixed methods approach. BMC Public Health, 2014; 14:596.
12.
SenkomagoV, SangrajrangS, KetgudeeL, SaraiyaM. Challenges in educating women about human papillomavirus (HPV) and HPV screening test results: Experience from an HPV demonstration project in North-Eastern Thailand. Papillomavirus Res, 2016; 2:190–192.
13.
OrtizAP, AlejandroN, PerezCM, et al.Acceptability of cervical and anal HPV self-sampling in a sample of Hispanic women in Puerto Rico. P R Health Sci J, 2012; 31:205–212.
14.
AnhangR, NelsonJA, TelerantR, ChiassonMA, WrightTCJr.Acceptability of self-collection of specimens for HPV DNA testing in an urban population. J Womens Health (Larchmt), 2005; 14:721–728.
15.
GuanY, CastlePE, WangS, et al.A cross-sectional study on the acceptability of self-collection for HPV testing among women in rural China. Sex Transm Infect, 2012; 88:490–494.
16.
ArbynM, VerdoodtF, SnijdersPJ, et al.Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: A meta-analysis. Lancet Oncol, 2014; 15:172–183.
17.
WallerJ, MarlowLA, WardleJ. The association between knowledge of HPV and feelings of stigma, shame and anxiety. Sex Transm Infect, 2007; 83:155–159.
18.
GarciaC, LothamerH, MitchellEM. Provider-identified barriers to cervical cancer screening and perceptions toward self-collection of human papillomavirus in Southwest Virginia. Public Health Nurs, 2016; 33:539–546.
19.
KatzML, ZimmermannBJ, MooreD, PaskettED, ReiterPL. Perspectives from healthcare providers and women about completing human papillomavirus (HPV) self-testing at home. Women Health, 2016:1–17.
20.
PresserBE, KatzML, ShobenAB, et al.Effects of an education intervention about HPV self-testing for healthcare providers and staff. J Cancer Educ, 2017 [Epub ahead of print]; DOI: 10.1007/s13187-017-1164-0.
21.
FDA approves first human papillomavirus test for primary cervical cancer screening [press release]. U.S Food and Drug Administration Website. Available at: www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm394773.htm Accessed February2, 2017.
22.
Final Research Plan: Cervical Cancer Screening. U.S. Preventive Services Task Force [updated June 2016]. Available at: www.uspreventiveservicestaskforce.org/Page/Document/final-research-plan/cervical-cancer-screening2 Accessed February2, 2017.
